Altre lingue Ajanta Pharma Limited

Azioni

AJANTPHARM

INE031B01049

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:40:28 05/07/2024			Variaz. 5gg	Var. 1 gen.
2.267 ^INR	+2,11%		-0,90%	+8,78%

03/05	TITOLI INDIA-Il Nifty 50 dell'India scivola dai massimi storici con il peso dei titoli IT	RE
02/05	L'utile consolidato di Ajanta Pharma quasi raddoppia nel quarto trimestre fiscale	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tranche Update on Ajanta Pharma Limited's Equity Buyback Plan announced on May 2, 2024.	21/06
Ajanta Pharma Limited's Equity Buyback announced on May 2, 2024, has closed with 1,028,881 shares, representing 0.81% for INR 2,850 million.	11/06
INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh	03/05
Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4	02/05
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	02/05
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	02/05
Ajanta Pharma Limited announces an Equity Buyback for 1,028,881 shares, representing 0.82% for INR 2,850 million.	02/05
Ajanta Pharma Limited Provides Revenue Guidance for the Fiscal Year 2025	02/05
Ajanta Pharma Limited authorizes a Buyback Plan.	02/05
Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024.	26/04
Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit	02/02
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024	31/01
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31/01
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024	25/01
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024	31/10/23
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	31/10/23
Ajanta Pharma Gets US FDA Nod for Topiramate Extended-Release Capsules	31/08/23
Ajanta Pharma Limited Receives Final Approval from US FDA for Topiram Extended Release Capsules	30/08/23
Ajanta Pharma Logs Increase in Fiscal Q1 Consolidated Profit	28/07/23
Ajanta Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ajanta Pharma Limited

Azioni

AJANTPHARM

INE031B01049

Altre lingue

Filtri